New Deal
Kasim Kutay
CEO at NOVO HOLDINGS A/S
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (27)
Key Relationships
Announcement Date
Deal Value
STRONGBRIDGE
Novo Holdings
value n/a
15 dealmakers
Btg
Boston Scientific Corporation
£3,029m
64 dealmakers
Wirb-copernicus Group
Leonard Green & Partners
12 dealmakers
SYMPHOGEN
Servier International
30 dealmakers
Eresearchtechnology
Astorg Partners
17 dealmakers
VECTIVBIO
Cormorant Asset Management
£84m
35 dealmakers
EVOTEC
Mubadala Investment Company
£226m
27 dealmakers
TEMPUS
Baillie Gifford & Co
£149m
Io Biotech
Lundbeckfonden Emerge
£113m
16 dealmakers
ALTASCIENCES
19 dealmakers
EXSCIENTIA
£71m
13 dealmakers
CORWAVE
£29m
8 dealmakers
Unchained Labs
The Carlyle Group
£313m
Noom
Silver Lake Partners
£381m
14 dealmakers
Esco Lifesciences Group
£141m
Availity
INBRACE
Venbio
£74m
11 dealmakers
METAGENOMI
MODERNA
£129m
INVETX
F-prime Capital
£49m
Dades As
5 dealmakers
Amolyt Pharma
Tekla Capital Management
£115m
18 dealmakers
Ellab
7 dealmakers
Hpnow Aps
Export And Investment Fund Of Denmark (eifo)
£12m
Acesion Pharma Aps
Alpha Wave Ventures
£39m
Commit Biologics
£9m
Catalent
£13,056m
94 dealmakers
Novo Holdings (three Fill-finish Sites)
Novo Nordisk
£8,704m
29 dealmakers